NEW YORK (Reuters Health) – A single annual injection of the bisphosphonate zoledronate effectively treats HIV-associated bone loss and is generally well tolerated, a study confirms. In HIV-infected…
NEW YORK (Reuters Health) – A test panel of four biomarkers of cerebral ischemia shows promise as an aid to early evaluation and management of patients with symptoms…
NEW YORK (Reuters Health) – Cow’s milk oral immunotherapy appears to desensitize milk allergic children, a study indicates, although further work is needed to determine optimal dosing and…
NEW YORK (Reuters Health) – The increasing prevalence of autism cases in California seen since the 1990s is in large part real, not simply the result of changes…
NEW YORK (Reuters Health) – The results of a sham-controlled trial suggest that pneumatic compression devices (PCDs) can produce clinically significant improvements in patients with restless legs syndrome.…
NEW YORK (Reuters Health) – As treatments for rheumatoid arthritis, rituximab and abatacept do not increase the risk of serious infections, a meta-analysis of trial data suggests. High…
NEW YORK (Reuters Health) – Treatment with the nonsteroidal selective estrogen receptor modulator raloxifene may heighten the risk of venous thromboembolic events and stroke deaths in postmenopausal women…
NEW YORK (Reuters Health) – In high-risk atrial fibrillation patients who are candidates for anticoagulation, stroke usually occurs if warfarin is not used or drug levels are subtherapeutic,…
NEW YORK (Reuters Health) – Among spontaneously breathing, very premature infants, surfactant therapy administered within the first hour of life along with nasal continuous positive airway pressure (CPAP)…
NEW YORK (Reuters Health) – In the largest cohort study to date, statin treatment was found to reduce the incidence of Alzheimer’s disease, regardless of the drug’s lipophilicity…
